secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001641172-25-008854
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharma stockholders approve reverse stock split up to 1-for-250 at special meeting
--------------------------------------------------------------------------------

- Proposal passed with 5,065,868 votes for, 496,473 against, 1,438 abstentions.
- Board may implement split at ratios from 1-for-2 to 1-for-100, aggregate not exceeding 1-for-250.
- The reverse stock split amendments to the certificate of incorporation have been authorized.
- Company's common stock trades under CDT on Nasdaq; warrants trade under CDTTW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225008854/0001641172-25-008854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225008854/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer